Trade Summary

1 week ago, Eckhardt Sue Gail, serving as Dir at Exelixis, Inc. (EXEL), sold 3,856 shares at $43.79 per share, for a total transaction value of $168,854.00. Following this transaction, Eckhardt Sue Gail now holds 17,524 shares of EXEL.

This sale represents a 18.00% decrease in Eckhardt Sue Gail's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, February 13, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 18, 2026, 5 days after the trade was made.

Exelixis, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.